ETON
Eton Pharmaceuticals IncNASDAQHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Key Statistics
Market Cap
$892.72M
P/E Ratio
—
EPS
$-0.06
Beta
0.82
52W High
$35.66
52W Low
$13.09
50-Day MA
$26.11
200-Day MA
$19.47
Dividend Yield
—
Profit Margin
-1.70%
Forward P/E
47.85
PEG Ratio
—
About Eton Pharmaceuticals Inc
Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and marketing pharmaceuticals for rare diseases. The company is headquartered in Deer Park, Illinois.
Fundamentals
| Revenue (TTM) | $86.93M |
| Gross Profit (TTM) | $51.92M |
| EBITDA | $11.09M |
| Operating Margin | 11.40% |
| Return on Equity | -5.36% |
| Return on Assets | 4.76% |
| Revenue/Share (TTM) | $3.22 |
| Book Value | $0.97 |
| Price-to-Book | 29.13 |
| Price-to-Sales (TTM) | 10.27 |
| EV/Revenue | 10.39 |
| EV/EBITDA | 145.64 |
| Quarterly Earnings Growth (YoY) | -12.60% |
| Quarterly Revenue Growth (YoY) | 40.40% |
| Shares Outstanding | $27.39M |
| Float | $21.00M |
| % Insiders | 4.93% |
| % Institutions | 65.43% |
Historical Volatility
HV 10-Day
62.85%
HV 20-Day
80.42%
HV 30-Day
78.79%
HV 60-Day
69.51%
HV Rank
99.2%
Volatility is currently contracting
Analyst Ratings
Consensus ($42.67 target)
3
BuyMore HEALTHCARE Stocks
Data last updated: 5/25/2026